I spent some time in my last two columns dissecting recent trends involving recalls for E. coli O157:H7 and allergens. While E. coli O157:H7 outbreaks and recalls were experiencing a sharp decline, recalls involving undeclared allergens seemed to be rocketing upward at an unprecedented pace.
Although I found these trends interesting, I was exceptionally curious to survey how industry was ranking with respect to its control of Listeria monocytogenes. What I learned surprised me.